Prognostic significance of left ventricular mass by magnetic resonance imaging study in patients with known or suspected coronary artery disease

Journal of Hypertension

Volumn 27, Issue 11, 2009, Pages 2249-2256

  Krittayaphong, Rungroj ^a   Boonyasirinant, Thananya ^a   Saiviroonporn, Pairash ^a   Thanapiboonpol, Prajak ^a   Nakyen, Supaporn ^a   Ruksakul, Krongkarn ^a   Udompunturak, Suthipol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cardiac magnetic resonance; Late gadolinium enhancement; Left ventricular mass; Prognosis

Indexed keywords

GADOLINIUM;

AGED; ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DEATH; DIAGNOSTIC VALUE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; UNSTABLE ANGINA PECTORIS;

EID: 73249116804     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283309ac4     Document Type: Article

References (35)

1. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141:334-341. (Pubitemid 32200259)
2. Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 1994; 73:1-5. (Pubitemid 24019991)
3. Boden WE, Kleiger RE, Schechtman KB, Capone RJ, Schwartz DJ, Gibson RS. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol 1988; 62:1000-1004. (Pubitemid 18267555)
4. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994; 272:33-36. (Pubitemid 24195443)
5. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000; 2:271-278.
6. Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995; 8:221-228.
7. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am Heart J 2004; 147:218-223. (Pubitemid 38176819)
8. Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002; 40:673-678. (Pubitemid 35278604)
9. Butler SP, McKay E, Paszkowski AL, Quinn RJ, Shnier RC, Donovan JT. Reproducibility study of left ventricular measurements with breath-hold cine MRI using a semiautomated voiumetric image analysis program. J Magn Reson Imaging 1998; 8:467-472. (Pubitemid 28150960)
10. Alfakih K, Bloomer T, Bainbridge S, Bainbridge G, Ridgway J, Williams G, Sivananthan M. A comparison of left ventricular mass between twodimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension. Eur J Radiol 2004; 52:103-109. (Pubitemid 39366003)
11. Krittayaphong R, Sheps DS. Relation between blood pressure at rest and perception of angina pectoris during exercise testing. Am J Cardiol 1996; 77:1224-1226. (Pubitemid 26186966)
12. Aguilar D, Goldhaber SZ, Gans DJ, Levey AS, Porush JG, Lewis JB, et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension and nephropathy. Am J Cardiol 2004; 94:337-339. (Pubitemid 38962699)
13. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22:6A-13A.
14. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113:2733-2743. (Pubitemid 43947991)
15. Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008; 118:1011-1020.
16. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51:2414-2421. (Pubitemid 351826874)
17. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969. (Pubitemid 30681627)
18. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordiai and limb leads. Am Heart J 1949; 37:161-186.
19. Dewey FE, Rosenthal D, Murphy DJ Jr, Froelicher VF, Ashley EA. Does size matter? Clinical appiications of scaling cardiac size and function for body size. Circulation 2008; 117:2279-2287.
20. Krittayaphong R, Saiviroonporn P, Boonyasirinant T, Nakyen S, Thanapiboonpol P, Udompunturak S. Accuracy of visual assessment in the detection and quantification of myocardial scar by delayedenhancement magnetic resonance imaging. J Med Assoc Thai 2007; 90 (Suppl 2):1-8.
21. Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004; 110:1456-1462. (Pubitemid 39238023)
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of TwoDimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
24. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R, et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004; 110:1814-1818. (Pubitemid 39299223)
25. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schomig A, Kastrati A. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol 2007; 50:149-156. (Pubitemid 47002186)
26. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006; 114:2871-2891. (Pubitemid 46018289)
27. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64.
28. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43:731-738. (Pubitemid 38405579)
29. Auerbach MA, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999; 99:2921-2926. (Pubitemid 29258981)
30. Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol 2006; 97:959-963.
31. Opie LH, Comrnerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006; 367:356-367.
32. McLenachan JM, Henderson E, Morris Kl, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317:787-792. (Pubitemid 17133358)
33. Kahan T, Bergfeldt L Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart 2005; 91:250-256.
34. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Am J Hypertens 2006; 19:493-499.
35. Tse HF, Cheung BM, Ng W, Chan JK, Devereux RB, Lau CP. Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes. J Card Fail 2003; 9:122-127. (Pubitemid 36444197)